Post-earnings recap
Reported
Wed, May 13, 2026
EPS actual
$0.26
EPS est.
$0.17
EPS surprise
+54.76%
1-day move
-11.57%
Doximity's earnings report shows a mixed performance, with EPS slightly below expectations while revenue figures were not disclosed. The stock reacted negatively, dropping 11.57%, likely due to the lack of revenue clarity and overall market sentiment. Investors may be concerned about the company's growth trajectory without clear guidance or commentary from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.26 | $0.28 | +54.76% |
| Revenue | — | $144M | — |
No transcript is on record, and the analysis is based on numerical results only.
Doximity, Inc. is a healthcare technology company that provides a digital platform for healthcare professionals to connect, collaborate, and access medical information. With a focus on improving communication and efficiency in the healthcare sector, Doximity plays a crucial role in the growing trend of digital health solutions.
Last quarter
In the last quarter, Doximity reported an EPS of $0.46, significantly exceeding the estimated $0.32, marking a 43.3% surprise. However, the stock declined by 5.48% the following day, indicating mixed market reactions despite strong earnings.
Management promises and guidance
EPS beat streak
4Q
EPS beat rate
88%
Avg EPS surprise
+50.41%
Avg 1-day reaction
-2.76%
Analysts are generally optimistic about Doximity's upcoming earnings, expecting a solid EPS of $0.28 and revenue of $144 million. However, the stock's recent performance suggests that even good results may not guarantee a positive market reaction.
Bull case
If Doximity beats EPS and revenue estimates, it could signal strong demand for its services and lead to a positive reassessment of its growth prospects.
Bear case
Conversely, if the company misses expectations or provides weak guidance, it could raise concerns about its growth trajectory and market position.
Key metrics to watch
EPS
0.28Earnings per share (EPS) is a key indicator of the company's profitability and performance relative to analyst expectations.
Revenue
144MRevenue figures will provide insight into the company's growth and demand for its services in the healthcare technology market.
The print will turn on these.
Q1
Will Doximity achieve an EPS of at least $0.28?
This number is critical as it sets the tone for market expectations and reflects the company's profitability.
Q2
What guidance will management provide for future revenue growth?
Future revenue guidance will indicate the company's growth trajectory and impact investor confidence.
—
Est. EPS
$-0.17
Est. Rev
$556M
Impl. Move
±11.3%
Why consensus could be wrong
The Street may be underestimating the impact of Doximity's recent platform enhancements on user engagement and revenue growth.
Supporting evidence
Doximity has consistently beaten EPS estimates, indicating stronger underlying performance.
The options market is pricing a significant move, suggesting that investors expect more volatility than historical trends would imply.
Key risk
If Doximity's revenue growth exceeds $150 million, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is weighing Doximity's ability to maintain growth in a competitive healthcare technology landscape.
Bull confirmed if
An EPS of $0.30 or higher with revenue exceeding $145 million would confirm the bull case.
Bear confirmed if
An EPS below $0.22 or revenue below $143 million would support the bear case.
What the market is pricing for the move.
Implied Move
±20.04%
Historical Avg
±3.6%
The options market is pricing in a significant potential move, suggesting that investors expect volatility around the earnings announcement.
Options are pricing ±20.0% while DOCS has averaged ±3.6% over the last 8 prints — setup is pricing rich.
ATM IV
2.7%
30d HV
42.9%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$0.00
0 sh
0 insiders
Sold
$92,275.90
3,290 sh
2 insiders
Net
$92,275.90
Net selling
Most Active Insiders· 2 open-market trades
Smart-money positioning from the most recent 13F filings.
Institutional
102.32%
of float
Insider
2.98%
of float
Holders
515
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
14,307,116 sh · $396.2M
11.23%
0.3%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Doximity beats expectations, history suggests a potential stock increase of around 0.14% on average, confirming positive market sentiment.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future growth.
Miss
Should Doximity miss estimates, history suggests an average decline of 0.72%, indicating negative market sentiment.
The lines on the call that would change the story.
$57,820.00
Net selling
$34,455.90
Net selling
Recent Transactions
Oct 1, 2026 · @ $28.91
2,000 sh
$57,820.00
Sep 30, 2026 · @ $26.71
1,290 sh
$34,455.90
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.
Vanguard Portfolio Management LLC
6,387,099 sh · $176.9M
5.02%
-0.1%
Vanguard Capital Management LLC
5,977,433 sh · $165.5M
4.69%
3.7%
Shaw D.E. & Co., Inc.
5,922,188 sh · $164.0M
4.65%
104.1%
Two Sigma Investments, LP
4,647,309 sh · $128.7M
3.65%
239.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.